Dynamics of antigen delivery and the functional roles of L121-adjuvant

Vaccine

Volumn 33, Issue 35, 2015, Pages 4341-4348

  Shen, Shan Shan ^a   Yang, Ya Wun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antigen delivery; CTL; Pluronic L121; Vaccine adjuvant

Indexed keywords

ADJUVANT; ANTIGEN; BOVINE SERUM ALBUMIN; FLUORESCEIN ISOTHIOCYANATE; L121 ADJUVANT; LIPOCORTIN 5; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; CASPASE; IMMUNOLOGICAL ADJUVANT; OVALBUMIN; POLOXAMER; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL COMPARTMENTALIZATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; GOLGI COMPLEX; IMMUNIZATION; INTRACELLULAR TRANSPORT; LYMPH NODE; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; THYMOMA CELL LINE; ANIMAL; C57BL MOUSE; IMMUNOLOGY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; BIOLOGICAL TRANSPORT; CASPASES; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNIZATION; LYMPH NODES; MACROPHAGES; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; OVALBUMIN; POLOXAMER; PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84939572330     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.04.051     Document Type: Article

References (36)

1. Brewer J.M., Conacher M., Satoskar A., Bluethmann H., Alexander J. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 1996, 26(9):2062-2066.
2. O'Hagan D.T., Ugozzoli M., Barackman J., Singh M., Kazzaz J., Higgins K., et al. Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1. Vaccine 2000, 18(Mar (17)):1793-1801.
3. Ke Y., Li Y., Kapp J.A. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur J Immunol 1995, 25(2):549-553.
4. Yang Y.W., Wu C.A., Morrow W.J. Cell death induced by vaccine adjuvants containing surfactants. Vaccine 2004, 22(11-12):1524-1536.
5. McLean S.C., Lioe H., Meagher L., Craig V.S., Gee M.L. Atomic force microscopy study of the interaction between adsorbed poly(ethylene oxide) layers: effects of surface modification and approach velocity. Langmuir 2005, 21(Mar (6)):2199-2208.
6. Shen S.S., Yang Y.W. Antigen delivery for cross priming via the emulsion vaccine adjuvants. Vaccine 2012, 30(Feb (9)):1560-1571.
7. Yang Y.W., Wei A.C., Shen S.S. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate-a revisit of the role of the hydrophile-lipophile balance (HLB) value. Vaccine 2005, 23(Apr (20)):2665-2675.
8. Raychaudhuri S., Tonks M., Carbone F., Ryskamp T., Morrow W.J., Hanna N. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci USA 1992, 89(17):8308-8312.
9. Yang Y.W., Shen S.S. Enhanced antigen delivery via cell death induced by the vaccine adjuvants. Vaccine 2007, 25(45):7763-7772.
10. Iyoda T., Shimoyama S., Liu K., Omatsu Y., Akiyama Y., Maeda Y., et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002, 195(10):1289-1302.
11. Platzer B., Stout M., Fiebiger E. Antigen cross-presentation of immune complexes. Front Immunol 2014, 5:140.
12. Brossart P., Bevan M.J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997, 90(Aug (4)):1594-1599.
13. Carbone F.R., Bevan M.J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 1990, 171(2):377-387.
14. Hari A., Ganguly A., Mu L., Davis S.P., Stenner M.D., Lam R., et al. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis. Eur J Immunol 2015, 45(February (2)):383-395.
15. Benes P., Vetvicka V., Fusek M. Cathepsin D-many functions of one aspartic protease. Crit Rev Oncol Hematol 2008, 68(Oct (1)):12-28.
16. Zaidi N., Maurer A., Nieke S., Kalbacher H. Cathepsin D: a cellular roadmap. Biochem Biophys Res Commun 2008, 376(Nov (1)):5-9.
17. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998, 16:323-358.
18. Nakamura N., Rabouille C., Watson R., Nilsson T., Hui N., Slusarewicz P., et al. Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol 1995, 131(Dec (6 Pt 2)):1715-1726.
19. Packard B.Z., Telford W.G., Komoriya A., Henkart P.A. Granzyme B activity in target cells detects attack by cytotoxic lymphocytes. J Immunol 2007, 179(Sep (6)):3812-3820.
20. Brunner K.T., Mauel J., Cerottini J.C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968, 14(2):181-196.
21. Liu L., Chahroudi A., Silvestri G., Wernett M.E., Kaiser W.J., Safrit J.T., et al. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med 2002, 8(2):185-189.
22. Liang X., Mao G., Ng K.Y. Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation. J Colloid Interface Sci 2005, 285(May (1)):360-372.
23. Hariharan K., Hanna N. Development and application of PROVAX (TM) adjuvant formulation for subunit cancer vaccines. Adv Drug Delivery Rev 1998, 32(3):187-197.
24. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176(6):1693-1702.
25. Bossuyt X., Marti G.E., Fleisher T.A. Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 1997, 30(Jun (3)):124-133.
26. Sheikh N.A., al Shamisi M., Morrow W.J. Delivery systems for molecular vaccination. Curr Opin Mol Ther 2000, 2(1):37-54.
27. Sheikh N.A., Attard G.S., van Rooijen N., Rajananthanan P., Hariharan K., Yang Y.W., et al. Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation. Vaccine 2003, 21(25-26):3775-3788.
28. Sheikh N.A., Rajananthanan P., Attard G.S., Morrow W.J. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants. Vaccine 1999, 17(23-24):2974-2982.
29. Kodani A., Sutterlin C. The Golgi protein GM130 regulates centrosome morphology and function. Mol Biol Cell 2008, 19(2):745-753.
30. Falguieres T., Luyet P.P., Gruenberg J. Molecular assemblies and membrane domains in multivesicular endosome dynamics. Exp Cell Res 2009, 315(May (9)):1567-1573.
31. Delamarre L., Pack M., Chang H., Mellman I., Trombetta E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005, 307(Mar (5715)):1630-1634.
32. de Saint Basile G., Menasche G., Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 2010, 10(8):568-579.
33. Dustin M.L., Long E.O. Cytotoxic immunological synapses. Immunol Rev 2010, 235(May (1)):24-34.
34. Jenkins M.R., Griffiths G.M. The synapse and cytolytic machinery of cytotoxic T cells. Curr Opin Immunol 2010, 22(Jun (3)):308-313.
35. Stinchcombe J.C., Griffiths G.M. Secretory mechanisms in cell-mediated cytotoxicity. Annu Rev Cell Dev Biol 2007, 23:495-517.
36. Trapani J.A., Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002, 2(10):735-747.